Researchers implemented daily chlorhexidine bathing for 16 months in a medical ICU with MRSA endemicity after a 14 month control period. They used regression analysis to find the affect of the bathing on MRSA acquisition, and they also measured MRSA chlorhexidine susceptibility with polymerase chain reaction tests.
They found a significant reduction in the incidence density of MRSA in the ICU.
“Daily chlorhexidine bathing resulted in a significantly decreasing trend of MRSA acquisition rates irrespective of increased MRSA prevalence rates in the medical ICU,” the study concludes. “There was no shift of chlorhexidine-resistant MRSA strains.”
More articles on chlorhexidine:
The growing body of evidence supporting CHG bathing
3 recent stories, studies on chlorhexidine
Triclosan or chlorhexidine: Which better prevents bacteria recolonization?
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
